AMGN34:BVMF
Amgen
94,59 R$
arrow_upward
+1,45%(+1,35) 1K
12-noy, 17:39:47 (GMT-3) · BRL
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMGN34 tikeri uchun statistika yaratilmoqda...
Ochish
94,26 R$
Yuqori
95,00 R$
Past
94,26 R$
Bozor kapitali
252,64 mlrd
Oʻrtacha hajm
298,00
Hajmi
4,15 ming
52 haftalik eng yuqori
95,00 R$
52 haftalik eng past
47,76 R$
Muomaladagi aksiyalar
540,91 mln
Xodimlar soni
32 ming
Ochish
94,26 R$
Yuqori
95,00 R$
Past
94,26 R$
Bozor kapitali
252,64 mlrd
Oʻrtacha hajm
298,00
Hajmi
4,15 ming
52 haftalik eng yuqori
95,00 R$
52 haftalik eng past
47,76 R$
Muomaladagi aksiyalar
540,91 mln
Xodimlar soni
32 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
2 soat oldin
Is Amgen Stock Priced Right Against Its Peers?
Investing.com
·
7 soat oldin
Argus raises Amgen stock price target on pipeline strength
Yahoo Finance
·
8 soat oldin
Amgen Inc. (AMGN) Stock Forecasts
TradingView
·
9 soat oldin
TScan Therapeutics Q3 revenue drops after Amgen collaboration ends
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5 ming
Asos solingan1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
SektorHealth Care
Soha-
Veb-saytamgen.com